Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

62.61 USD +0.70 (+1.13%)
Official Closing Price Updated: 7:59 PM EDT, Apr 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,867,900
Open 61.80
Bid (Size) 62.45 (4)
Ask (Size) 62.82 (1)
Prev. Close 61.91
Today's Range 61.68 - 62.64
52wk Range 54.07 - 67.16
Shares Outstanding 1,634,538,458
Dividend Yield 3.13%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Neoadjuvant Opdivo (nivolumab) Plus Chemotherapy Significantly Improves Pathologic Complete Response in Patients with Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial
Neoadjuvant Opdivo + Chemotherapy Significantly Improves Pathologic Complete Response in Patients w/ Resectable NSCLC in Phase 3 CheckMate -816 Trial 
From Business Wire News Releases
CORRECTING and REPLACING Bristol Myers Squibb Announces Opdivo (nivolumab) plus Chemotherapy and Opdivo plus Yervoy (ipilimumab) Demonstrate Superior Survival Benefit Compared to Chemotherapy in Unre
BMS Announces Opdivo plus Chemotherapy and Opdivo plus Yervoy Demonstrate Superior Survival Benefit Compared to Chemotherapy..... 
From Business Wire News Releases

Performance

YTD
+2.00%
+2.00%
1 Month
+3.74%
+3.74%
3 Month
-3.63%
-3.63%
6 Month
+1.26%
+1.26%
1 Year
+6.26%
+6.26%

More News

Read More
PsiOxus Therapeutics Updates Agreement with Bristol Myers Squibb to Advance their Clinical Stage Immuno-Oncology Collaboration
From Business Wire News Releases
Best Health Care Stocks To Watch This Week? 4 In Focus
Tags Market News
From StockMarket.com
IMMP Stock: The Big Patent News Boosting Immutep Today
Tags MRK Market News BMY
From InvestorPlace
Bristol-Myers' Opdivo-Chemo Combo Associated With Overall Survival Benefit In Esophageal Cancer
Tags Biotech Briefs Market News
From Benzinga
PsiOxus Therapeutics-Bristol Myers Expand Immuno-Oncology Collaboration
Tags Biotech Briefs Market News
From Benzinga
Novel Cancer Therapy Phase 3 Trial Expects To Be Completed Shortly
Tags Markets Small Cap FUSN
From Benzinga
Does 2021's Best Biopharma to Work for Belong in Your Portfolio?
Tags VRTX SGEN PFE
From Motley Fool
7 Stocks That Could Double by Summer
Tags CRDF CIDM BMY
From InvestorPlace
Benzinga's Bulls And Bears Of The Week: Apple, GM, JetBlue, Lululemon, Tesla And More
Tags NIO Credit Suisse AAPL
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.